skip to main content

SABA overuse — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory TherapeuticsSABA overuseGPhC CRA

A 24-year-old with asthma requests a third salbutamol inhaler in eight weeks. The PMR shows no ICS-containing inhaler in the past year. He is comfortable at rest but reports waking with wheeze twice weekly. What is the most appropriate pharmacy response?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Provide reliever access and arrange same-week review of ICS-containing treatment

Repeated SABA requests, night waking and absence of ICS-containing treatment indicate poor control and increased risk. The patient should retain access to rescue treatment when a supply is clinically indicated, but SABA-only management is unsuitable. Current NICE guidance for people aged 12 and over uses ICS/formoterol AIR or MART pathways, alongside review of technique, adherence, reliever use and the personalised action plan.

Reference: NICE NG245, Asthma diagnosis, monitoring and chronic management: https://www.nice.org.uk/guidance/ng245/chapter/Recommendations